ACTRN12615000333516终止4 期
The effects of liraglutide vs insulin on glycaemic control in inpatients with glucocorticoid-induced diabetes
Alfred Hospital0 个研究点目标入组 30 人开始时间: 2015年4月13日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Glucocorticoid-induced or exacerbated diabetes treated with insulin and/or oral glucose-lowering medication(s)
- •Glucose >= 15 mmol/l
排除标准
- •Type 1 diabetes
- •Admission to intensive care
- •Likely to require surgical intervention
- •Likely to be admitted <48 h
- •eGFR <15 ml/min
- •Acute vomiting or history of gastroparesis
- •Known allergy to insulin or GLP-1 agonists
- •Proliferative retinopathy
- •Premenopausal females
研究者
相似试验
进行中（未招募）
1 期
The impact of liraglutide on glucose tolerance and the risk of type 2 diabetes in women with previous gestational diabetes mellitusGestational diabetes mellitus Non-alcoholic fatty liver diseaseMedDRA version: 20.0 Level: LLT Classification code 10018210 Term: Gestational diabetes mellitus System Organ Class: 100000004868MedDRA version: 20.1 Level: PT Classification code 10029530 Term: Non-alcoholic fatty liver System Organ Class: 10019805 - Hepatobiliary disordersEUCTR2012-001371-37-DKDr. med. Tina Vilsbøll160
已完成
2 期
Comparison of glucose control by added liraglutide to only insulin infusion in DM patient undergoing cardiac surgery: A randomized-controlled trialGlycemic variability in diabetic patients who undergo the cardiac surgeryGlycemic Variability: GV = Coefficient of variation = standard deviation/meanLiraglutide Drug = VictozaTMContinuous glucose monitoring = IPro2MedtronicTCTR20190118012Chulalongkorn University60
已完成
不适用
Effect of dulaglutide versus liraglutide on glucose variability and oxidative stress and endothelial function in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000034353Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine50
进行中（未招募）
1 期
The effect of a new anti-diabetic drug (Liraglutide) on body weight in patients with type 2 diabetes mellituspatients with type 2 diabetes mellitusMedDRA version: 14.0Level: PTClassification code 10053247Term: Insulin-requiring type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-000411-12-NLMC St Radboud80
进行中（未招募）
不适用
The influence of liraglutide on hypoglycaemia counterregulation and insulin secretion in type 2 diabeticsType 2 diabetesMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2010-023107-10-DESt. Josef-Hospital, Ruhr University, Bochum